The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Age at disability milestones in multiple sclerosis
Abstract
Many efforts have been devoted to the description of the prognosis of multiple sclerosis and its possible influential factors in terms of time to reach disability milestones. By contrast, the age at which patients with multiple sclerosis reach these milestones has not yet stirred much interest. We have tested the hypothesis whether the prognosis of multiple sclerosis depends on the current age of patients and the initial course of the disease. We have assessed disease onset and course, and assignment of scores of irreversible disability in 1844 patients with multiple sclerosis. We have used three scores on the Kurtzke Disability Status Scale as benchmarks of disability accumulation: DSS 4 (limited walking but without aid), DSS 6 (walking with unilateral aid) and DSS 7 (wheelchair-bound). We used Kaplan-Meier analyses to estimate the age of the patients at assignment of disability milestones. The possible influence of the initial course of multiple sclerosis and of other clinical variables early assessable in the disease on these outcome measures was also studied, using the Kaplan-Meier curves for univariate analyses and Cox models for multivariate analyses. For the 1844 patients, median ages at time of assignment of irreversible disability were 44.3 years (95% CI 43.3-45.2) for a score of DSS 4, 54.7 years (95% CI 53.5-55.8) for DSS 6 and 63.1 years (95% CI 61.0-65.1) for DSS 7. These results were essentially similar whether the initial course of multiple sclerosis was exacerbating-remitting or progressive, and whatever the initial symptomatology. Females reached disability milestones at an older age than males. The most influential clinical factor was age at clinical onset of multiple sclerosis: the younger the onset, the younger the age at assignment of disability milestones. Therefore, prognosis in multiple sclerosis appears, at least to some extent, as age-dependent and not substantially affected by the initial course, be it exacerbating-remitting or progressive. Aside acute focal recurrent inflammation and diffuse chronic neurodegeneration, accelerated ageing-related mechanisms may operate in the central nervous system of multiple sclerosis patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
Poser, C. M., Paty, D. W., Scheinberg, L., McDonald, W. I., Davis, F. A., Ebers, G. C., Johnson, K. P., Sibley, W. A., Silberberg, D. H., & Tourtellotte, W. W. (1983) · Annals of Neurology · doi:10.1002/ana.410130302 · Cited by 7,384
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Oxidative Stress, Caloric Restriction, and Aging
Sohal, R. S., & Weindruch, R. (1996) · Science · doi:10.1126/science.273.5271.59 · Cited by 3,131
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Compston, A., & Coles, A. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08220-x · Cited by 1,743
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.1.133 · Cited by 1,452
Schumacher, G. A., Beebe, G., Kibler, R. F., Kurland, L. T., Kurtzke, J. F., McDowell, F., Nagler, B., Sibley, W. A., Tourtellotte, W. W., & Willmon, T. L. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb20235.x · Cited by 1,438
Relapses and Progression of Disability in Multiple Sclerosis
Confavreux, C., Vukusic, S., Moreau, T., & Adeleine, P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011163432001 · Cited by 1,309
Self-citationThe natural history of multiple sclerosis:a geographically based study
Cottrell, D. A., Kremenchutzky, M., Rice, G. P. A., Koopman, W. J., Hader, W., Baskerville, J., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.4.625 · Cited by 1,163
Confavreux, C. (2003) · Brain · doi:10.1093/brain/awg081 · Cited by 996
Self-citationSim, F. J., Zhao, C., Penderis, J., & Franklin, R. J. M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02451.2002 · Cited by 625
WEINSHENKER, B. G., BASS, B., RICE, G. P. A., NOSEWORTHY, J., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1989) · Brain · doi:10.1093/brain/112.6.1419 · Cited by 602
Prognostic factors in a multiple sclerosis incidence cohort with twenty-five years of follow-up
Runmarker, B., & Andersen, O. (1993) · Brain · doi:10.1093/brain/116.1.117 · Cited by 568
CONFAVREUX, C., AIMARD, G., & DEVIC, M. (1980) · Brain · doi:10.1093/brain/103.2.281 · Cited by 494
Self-citationWEINSHENKER, B. G., RICE, G. P. A., NOSEWORTHY, J. H., CARRIERE, W., BASKERVILLE, J., & EBERS, G. C. (1991) · Brain · doi:10.1093/brain/114.2.1045 · Cited by 401
On the evaluation of disability in multiple sclerosis
Kurtzke, J. F. (1961) · Neurology · doi:10.1212/wnl.11.8.686 · Cited by 330
EDMUS, a European database for multiple sclerosis.
Confavreux, C., Compston, D. A., Hommes, O. R., McDonald, W. I., & Thompson, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.8.671 · Cited by 313
Self-citationYOUL, B. D., TURANO, G., MILLER, D. H., TOWELL, A. D., MACMANUS, D. G., MOORE, S. G., JONES, S. J., BARRETT, G., KENDALL, B. E., MOSELEY, I. F., et al. (1991) · Brain · doi:10.1093/brain/114.6.2437 · Cited by 259
Some Aspects of the Natural History of Disseminated Sclerosis
(2015) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/21.2.135 · Cited by 237
Eriksson, M., Andersen, O., & Runmarker, B. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms914oa · Cited by 221
Management of Multiple Sclerosis
Rudick, R. A., Cohen, J. A., Weinstock-Guttman, B., Kinkel, R. P., & Ransohoff, R. M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372207 · Cited by 201
Age‐related disability in multiple sclerosis
Trojano, M., Liguori, M., Bosco Zimatore, G., Bugarini, R., Avolio, C., Paolicelli, D., Giuliani, F., De Robertis, F., Marrosu, M. G., & Livrea, P. (2002) · Annals of Neurology · doi:10.1002/ana.10147 · Cited by 186
The natural history of multiple sclerosis: a geographically based study
Kremenchutzky, M., Cottrell, D., Rice, G., Hader, W., Baskerville, J., Koopman, W., & Ebers, G. C. (1999) · Brain · doi:10.1093/brain/122.10.1941 · Cited by 186
Myhr, K., Riise, T., Vedeler, C. A., Nortvedt, M. W., Grønning, M., Midgard, R., & Nyland, H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700110 · Cited by 184
Polyneuropathies of Undetermined Cause
PRINEAS, J. (1970) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1970.tb07459.x · Cited by 170
Survival and predictors of disability in Turkish MS patients
Kantarci, O., Siva, A., Eraksoy, M., Karabudak, R., Sütlaş, N., Ağaoğlu, J., Turan, F., Özmenoğlu, M., Toğrul, E., Demirkiran, M., et al. (1998) · Neurology · doi:10.1212/wnl.51.3.765 · Cited by 168
Studies on the natural history of multiple sclerosis—8
Kurtzke, J. F., Beebe, G. W., Nagler, B., Kurland, L. T., & Auth, T. L. (1977) · Journal of Chronic Diseases · doi:10.1016/0021-9681(77)90010-8 · Cited by 165
Trojano, M., Avolio, C., Manzari, C., Calò, A., Robertis, F. D., Serio, G., & Livrea, P. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.58.3.300 · Cited by 147
PHADKE, J. G. (1990) · Brain · doi:10.1093/brain/113.6.1597 · Cited by 134
Course and prognosis of chronic progressive multiple sclerosis: Results of an epidemiological study
Minderhoud, J. M., van der Hoeven, J. H., & Prange, A. J. A. (1988) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1988.tb03611.x · Cited by 126
Vukusic, S., & Confavreux, C. (2003) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00426-4 · Cited by 126
Self-citationAge at onset, initial symptomatology and the course of multiple sclerosis
Poser, S., Raun, N. E., & Poser, W. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1982.tb06856.x · Cited by 122
Perforation of the Infarcted Interventricular Septum Diagnosed Ante Mortem.
GRELLAND, R. (1949) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1949.tb09331.x · Cited by 117
A prospective study on the prognosis of multiple sclerosis
Amato, M. P., & Ponziani, G. (2000) · Neurological Sciences · doi:10.1007/s100720070021 · Cited by 108
STUDIES ON THE NATURAL HISTORY OF MULTIPLE SCLEROSIS
Nagler, B., Beebe, G. W., Kurtzke, J. F., Kurland, L. T., Auth, T. L., & Nefzger, M. D. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1966.tb02012.x · Cited by 107
Early prognostic factors for disability in multiple sclerosis, a European multicenter study
Riise, T., Grønning, M., Fernández, Ó., Lauer, K., Midgard, R., Minderhoud, J. M., Nyland, H., Pálffy, G., Poser, S., & Aarli, J. A. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb04031.x · Cited by 103
Chari, D. M., Crang, A. J., & Blakemore, W. F. (2003) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/62.9.908 · Cited by 92
The natural history of multiple sclerosis: a regional study with some longitudinal data.
Miller, D. H., Hornabrook, R. W., & Purdie, G. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.5.341 · Cited by 90
Clinical studies on multiple sclerosis
Broman, T., Andersen, O., & Bergmann, L. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1981.tb00745.x · Cited by 84
Studies on the Natural History of Multiple Sclerosis: V. Long-Term Survival in Young Men
Kurtzke, J. F., Beebe, G. W., Nagler, B., Nefzger, M. D., Auth, T. L., & Kurland, L. T. (1970) · Archives of Neurology · doi:10.1001/archneur.1970.00480210025003 · Cited by 79
The course of multiple sclerosis in 73 cases with computer-designed curves.
Fog, T., & Linnemann, F. (1970) · PubMed · Cited by 73
STUDIES ON NATURAL HISTORY OF MULTIPLE SCLEROSIS
Kurtzke, J. F., Beebe, G. W., Nagler, B., Auth, T. L., Kurland, L. T., & Nefzger, M. D. (1968) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1968.tb05587.x · Cited by 69
Onset symptoms as predictors of mortality and disability in multiple sclerosis
Visscher, B. R., Liu, K.-S., Clark, V. A., Detels, R., Malmgren, R. M., & Dudley, J. P. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1984.tb00832.x · Cited by 68
Age Dependence of Clinical and Pathological Manifestations of Autoimmune Demyelination
Smith, M. E., Eller, N. L., McFarland, H. F., Racke, M. K., & Raine, C. S. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65218-2 · Cited by 65
Factors Associated With a Rapid Course of Multiple Sclerosis
Detels, R., Clark, V. A., Valdiviezo, N. L., Visscher, B. R., Malmgren, R. M., & Dudley, J. P. (1982) · Archives of Neurology · doi:10.1001/archneur.1982.00510180015003 · Cited by 62
Enhancement frequency decreases with increasing age in relapsing-remitting multiple sclerosis
Filippi, M., Wolinsky, J. S., PhD, M. P. S., Comi, G., & the European/Canadian Glatiramer Acetate Study Group* (2001) · Neurology · doi:10.1212/wnl.56.3.422 · Cited by 58
Natural history of multiple sclerosis: implications for counselling and therapy
Confavreux, C., & Vukusic, S. (2002) · Current Opinion in Neurology · doi:10.1097/00019052-200206000-00006 · Cited by 49
Self-citationEuropean validation of a standardized clinical description of multiple sclerosis
Amato, M. P., Grimaud, J., Achiti, I., Bartolozzi, M. L., Adeleine, P., Hartung, H.-P., Kappos, L., Thompson, A. J., Trojano, M., Vukusic, S., et al. (2004) · Journal of Neurology · doi:10.1007/s00415-004-0567-0 · Cited by 45
Self-citationClinical studies of multiple sclerosis in Israel
Leibowitz, U., Alter, M., & Halpern, L. (1964) · Neurology · doi:10.1212/wnl.14.10.926 · Cited by 44
The many roles of apoptosis in immunity as modified by aging and nutritional status.
Pj, F., & Da, L.-E. (2004) · PubMed · Cited by 40
Multiple sclerosis: an ańalysis of 812 cases by means of electronic data processing.
Poser, S. (1978) · PubMed · Cited by 35
Kassubek, J., Tumani, H., Ecker, D., Kurt, A., Ludolph, A. C., & Juengling, F. D. (2003) · Neuroreport · doi:10.1097/00001756-200303030-00026 · Cited by 34
[South-Eastern France, a high risk area for multiple sclerosis?].
Confavreux, C., Darchy, P., Alpérovitch, A., Aimard, G., & Devic, M. (1987) · PubMed · Cited by 18
Self-citation
Research works printed but not linked: 5
- Clark VA, Detels R, Visscher BR, Valdiviezo NL, Malmgren RM, Dudley JP. Factors associated with a malignant or benign course of multiple sclerosis. J Am Med Assoc1982; 248: 856–60. · DOI
- Confavreux C, Darchy P, Alperovitch A, Aimard G, Devic M. Le sud-Est français, zone ‘à haut risque’ de Sclérose en Plaques? Presse Med1987; 16: 622–3.
- Leibowitz U, Halpern L, Alter M. Clinical studies of multiple sclerosis in Israel. I. A clinical analysis based on a country-wide survey. Arch Neurol1964; 10: 502–12. · doi:10.1001/archneur.1964.00460170072011
- Leibowitz U, Alter M. Clinical factors associated with increased disability in multiple sclerosis. Acta Neurol Scand1970; 46: 53–70. · doi:10.1111/j.1600-0404.1970.tb05604.x
- Müller R. Course and prognosis of disseminated sclerosis in relation to age at onset. Arch Neurol Psychiatry1951; 66: 561–70. · doi:10.1001/archneurpsyc.1951.02320110026002
Cited by
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
Trapp, B. D., & Nave, K.-A. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094313 · Cited by 1,724
Progressive multiple sclerosis: pathology and pathogenesis
Lassmann, H., van Horssen, J., & Mahad, D. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.168 · Cited by 1,033
Natural history of multiple sclerosis: a unifying concept
Confavreux, C., & Vukusic, S. (2006) · Brain · doi:10.1093/brain/awl007 · Cited by 905
Self-citationFisniku, L. K., Brex, P. A., Altmann, D. R., Miszkiel, K. A., Benton, C. E., Lanyon, R., Thompson, A. J., & Miller, D. H. (2008) · Brain · doi:10.1093/brain/awm329 · Cited by 897
Metadata
- Authors
- Confavreux, C., & Vukusic, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-16
- Volume
- 129
- Issue
- 3
- Pages
- 595-605
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2099647077
- Cited by
- 525
- References
- 55
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.